NCT06423729CompletedPhase 2
Effect of Nicorandil in Type 2 Diabetic Obese Patients
Clinical Study Evaluating the Effect of Nicorandil in Type 2 Diabetic Obese Patients Treated With Sulfonylurea
Source: ClinicalTrials.gov · Last updated 12 Aug 2026
Brief summary (registry, in English)
1. Evaluating the effect of nicorandil on glycemic control of diabetic obese patients treated with sulfonylureas. 2. Investigating the effect of nicorandil on body weight of diabetic obese patients treated with sulfonylureas.
- Status (registry)
- Completed
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 46 (actual)
- First submitted
- 16 May 2024
- Start date
- 1 Nov 2023
- Primary completion date
- 30 Jul 2024
- Lead sponsor
- Tanta University
- Diseases
- Obesity, Type 2 diabetes
- NCT number
- NCT06423729
What you commit to
- Study type: Interventional · Phase 2
- Participants enrolled: 46
- From 1 Nov 2023 to the primary completion date, 30 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with hypersensitivity to nicorandil.
- Uncontrolled hypertension and its antihypertensive medications
- Severe renal or hepatic disease.
Other
- Pregnant and lactating females.
Who the study is looking for
- Patients newly diagnosed with diabetes .
- Body mass index (BMI) \>30 Kg/m2.
- The selected patients are treated with sulfonylureas alone.
- The age of selected patient ranged from 18 and 60 years.
Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Faculty of Pharmacy, Tanta University Coordinator of this site? Confirm its status | Tanta | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.